Skip to main content
SpringerLink
Log in

Coagulation Abnormalities in Critical Illness

  • Chapter
Mechanisms of Organ Dysfunction in Critical Illness

Part of the book series: Update in Intensive Care and Emergency Medicine ((UICMSOFT,volume 38))

  • 104 Accesses

Abstract

In critically ill patients coagulation abnormalities often occur. The most pronounced manifestation of these, caused by overwhelming activation of the coagulation system, is disseminated intravascular coagulation (DIC) which is also considered to be a component of the multiple organ dysfunction syndrome (MODS). There is no generally accepted definition of DIC but recently a working definition has been proposed [1]: “DIC is an acquired syndrome characterized by the activation of intravascular coagulation up to intravascular fibrin formation, which may be accompanied by secondary fibrinolysis or inhibited fibrinolysis”. DIC is not a disease entity but rather a syndrome which can complicate a large variety of clinical disorders mostly characterized by high morbidity and mortality. In general, DIC is therefore an indication of severe underlying disease. In critical illness acute, rather than chronic, low grade DIC may complicate the course of disease.

This is a preview of subscription content, log in via an institution to check access.

Access this chapter

Log in via an institution
Chapter
USD 29.95
Price excludes VAT (USA)
  • Available as PDF
  • Read on any device
  • Instant download
  • Own it forever
eBook
USD 89.00
Price excludes VAT (USA)
  • Available as EPUB and PDF
  • Read on any device
  • Instant download
  • Own it forever
Softcover Book
USD 119.99
Price excludes VAT (USA)
  • Compact, lightweight edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info
Hardcover Book
USD 169.99
Price excludes VAT (USA)
  • Durable hardcover edition
  • Dispatched in 3 to 5 business days
  • Free shipping worldwide - see info

Tax calculation will be finalised at checkout

Purchases are for personal use only

Institutional subscriptions

Preview

Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.

References

  1. Müller-Berghaus G, Ten Cate H, Levi M (1999) Disseminated intravascular coagulation: clinical spectrum and established as well as new diagnostic approaches. Thromb Haemost 82:706–712

    PubMed  Google Scholar 

  2. Levi M, De Jonge E, Van der Poll T, Ten Cate H (1999) Disseminated intravascular coagulation. Thromb Haemost 82:695–705

    PubMed  CAS  Google Scholar 

  3. Vervloet MG, Thijs LG, Hack CE (1998) Derangements of coagulation and fibrinolysis in critically ill patients with sepsis and septic shock. Semin Thromb Haemost 24:33–44

    Article  CAS  Google Scholar 

  4. Rangel-Frausto MS, Pittet D, Costigan M. Hwang T, Davis CS, Wenzel RP (1995) The natural history of the systemic inflammatory response syndrome (SIRS). A prospectice study. JAMA 273:117–123

    Article  PubMed  CAS  Google Scholar 

  5. Hulka F, Mullins RJ, Frank EH (1996) Blunt brain injury activates the coagulation process. Arch Surg 131:923–928

    Article  PubMed  CAS  Google Scholar 

  6. Scherer RU, Spangenberg P (1998) Procoagulant activity in patients with isolated severe head trauma. Crit Care Med 26:149–156

    Article  PubMed  CAS  Google Scholar 

  7. Gando S, Nanzaki S, Sasaki S, Kemmotsu O (1998) Significant correlations between tissue factor and thrombin markers in trauma and septic patients with disseminated intravascular coagulation. Thromb Haemost 79:1111–1115

    PubMed  CAS  Google Scholar 

  8. Gando S, Nanzaki S, Kemmotsu O (1999) Disseminated intravascular coagulation and sustained systemic inflammatory response syndrome predict organ dysfunctions after trauma. Ann Surg 229:121–127

    Article  PubMed  CAS  Google Scholar 

  9. Tapper H, Herwald H (2000) Modulation of hemostatic mechanisms in bacterial infectious diseases. Blood 96:2329–2337

    PubMed  CAS  Google Scholar 

  10. De Jonge E, Dekkers PEP, Creasey AA, et al (2000) Tissue factor pathway inhibitor (TFPI) dose-dependently inhibits coagulation activation without influencing the fibrinolytic and the cytokine response during human endotoxemia. Blood 95:1124–1129

    PubMed  Google Scholar 

  11. Pixley RA, De La Cadena R, Page JD, et al (1993) The contact system contributes to hypotension but not disseminated intravascular coagulation in lethal bacteremia. J Clin Invest 91:61–68

    Article  PubMed  CAS  Google Scholar 

  12. Hack CE (2000) Tissue factor pathway of coagulation in sepsis. Crit Care Med 28:S25–S30

    Article  PubMed  CAS  Google Scholar 

  13. Hack CE, Aarden LA, Thijs LG (1997) Role of cytokines in sepsis. Adv Immunol 66:101–195

    Article  PubMed  CAS  Google Scholar 

  14. Gando S, Nakanishi Y, Tedo I (1995) Cytokines and plasminogen activator inhibitor-1 in posttrauma disseminated intravascular coagulation: relationship to multiple organ dysfunction syndrome. Crit Care Med 23:1835–1842

    Article  PubMed  CAS  Google Scholar 

  15. Neugebauer E, Hensler T, Rose S, et al (2000) Das schwere Schädel-Hirn-Trauma beim Mehrfachverletzten. Der Unfallchirurg 103:122–131

    Article  PubMed  CAS  Google Scholar 

  16. Schwager I, Jungi ThW (1994) Effect of human recombinant cytokines on the induction of macrophage procoagulant activity. Blood 83:152–160

    PubMed  CAS  Google Scholar 

  17. Neumann F-J, Ott I, Marx N, et al (1997) Effect of human recombinant Interleukin-6 and Interleukin-8 on monocyte procoagulant activity. Arterioscler Thromb Vasc Biol 17:3399–3405

    Article  PubMed  CAS  Google Scholar 

  18. Gando S, Kameue T, Nanzaki S, Hayakawa T, Nakanishi Y (1997) Participation of tissue factor and thrombin in posttraumatic systemic inflammatory syndrome. Crit Care Med 25:1820–1826

    Article  PubMed  CAS  Google Scholar 

  19. Gando S, Nanzaki S, Sasaki S, Aoi K, Kemmotsu O (1998) Activation of the extrinsic coagulation pathway in patients with severe sepsis and septic shock. Crit Care Med 26:2005–2009

    Article  PubMed  CAS  Google Scholar 

  20. Franco RF, De Jonge E, Dekkers PEP, et al (2000) The in vivo kinetics of tissue factor messenger RNA expression during human endotoxemia: relationship with activation of coagulation. Blood 96:554–559

    PubMed  CAS  Google Scholar 

  21. Satta N, Toti F, Feugeas O, et al (1994) Monocyte vesiculation is a possible mechanism for dissemination of membrane-associated procoagulant activities and adhesion molecules after stimulation by lipopolysaccharide. J Immunol 153:3245–3255

    PubMed  CAS  Google Scholar 

  22. Nieuwland R, Berckmans RJ, McGregor S, et al (2000) Cellular origin and procoagulant properties of microparticles in meningococcal sepsis. Blood 95:930–935

    PubMed  CAS  Google Scholar 

  23. Takahashi H, Urano T, Nagai N, Takada Y, Takada A (2000) Neutrophil elastase may play a key role in developing symptomatic disseminated intravascular coagulation and multiple organ failure in patients with head injury. J Trauma 49:86–91

    Article  CAS  Google Scholar 

  24. Van der Poll T, Biiller HR, Ten Cate H, et al (1990) Activation of coagulation after administration of tumor necrosis factor to normal subjects. N Engl J Med 322:1622–1627

    Article  PubMed  Google Scholar 

  25. Jansen PM, Boermeester MA, Fischer E, et al (1995) Contribution of interleukin-1 to activation of coagulation and fibrinolysis, neutrophil degranulation, and the release of secretorytype phospholipase A2 in sepsis: studies in nonhuman primates after interleukin-1 a administration and during lethal bacteremia. Blood 86:1027–1034

    PubMed  CAS  Google Scholar 

  26. Lauw FN, Dekkers PEP, Te Velde AA, et al (1999) Interleukin-12 induces sustained activation of multiple host inflammatory mediator systems in chimpanzees. J Infect Dis 179:646–652

    Article  PubMed  CAS  Google Scholar 

  27. Van der Poll T, Jansen PM, Van Zee J, et al (1997) Pretreatment with a 55-kDa tumor necrosis factor receptor-immunoglobulin fusion protein attenuates activation of coagulation, but not of fibrinolysis, during lethal bacteremia in baboons. J Infect Dis 176:296–299

    Article  PubMed  Google Scholar 

  28. Stouthard JML, Levi M, Hack CE et al. (1996) Interleukin-6 stimulates coagulation, not fibrinolysis, in humans. Thromb Haemost 76:738–742

    PubMed  CAS  Google Scholar 

  29. Van der Poll T, Levi M, Hack CE et al. (1994) Elimination of Interleukin-6 attenuates coagulation activation in experimental endotoxemia in chimpanzees. J Exp Med 179:1253–1259

    Article  PubMed  Google Scholar 

  30. Hack CE and Colman RW (1999) The role of the contact system in the pathogenesis of septic shock. Sepsis 3:111–118

    Article  Google Scholar 

  31. Jansen PM, Pixley RA, Brouwer M, et al (1996) Inhibition of factor XII in septic baboons attenuates the activation of complement and fibrinolytic systems and reduces the release of interleukin-6 and neutrophil elastase. Blood 87:2337–2344

    PubMed  CAS  Google Scholar 

  32. Pixley RA, De La Cadena RA, Page JD, et al (1992) Activation of the contact system in lethal hypotensive bacteremia in a baboon model. Am J Pathol 140:897–906

    PubMed  CAS  Google Scholar 

  33. Creasey AA (1999) New potential therapeutic modalities: tissue factor pathway inhibitor. Sepsis 3:173–182

    Article  Google Scholar 

  34. Opal SM and Thijs LG (1999) New potential therapeutic modalities: antithrombin III. Sepsis 3:153–159

    Article  Google Scholar 

  35. Esmon ChT (1999) New potential therapeutic modalities: aPC. Sepsis 3:161–171

    Article  Google Scholar 

  36. Gando S, Nakanishi Y, Karneue T, Nanzaki S (1995) Soluble thrombomodulin increases in patients with disseminated intravascular coagulation and in those with multiple organ dysfunction syndrome after trauma: Role of neutrophil elastase. J Trauma 39:660–664

    Article  PubMed  CAS  Google Scholar 

  37. Niessen RWLM, Lamping RJ, Jansen PM, et al (1997) Antithrombin acts as a negative acute phase protein as established with studies on HepG2 cells and in baboons. Thromb Haemost 78:1088–1092

    PubMed  CAS  Google Scholar 

  38. Nuijens JH, Eerenberg-Belmer AJM, Huijbregts CCM, et al (1989) Proteolytic inactivation of plasma C1-inhibitor in sepsis. J Clin Invest 84:443–450

    Article  PubMed  CAS  Google Scholar 

  39. Bouma BN, Meijers JCM (1999) Fibrinolysis and the contact system: a role for factor XI in the down-regulation of fibrinolysis. Thromb Haemost 82:243–250

    PubMed  CAS  Google Scholar 

  40. Minnema MC, Friederich PW, Levi M, et al (1998) Enhancement of rabbit jugular vein thrombolysis by neutralization of factor XI. In vivo evidence for a role of factor XI as an antifibrinolytic factor. J Clin Invest 101:10–14.

    Article  PubMed  CAS  Google Scholar 

  41. Minnema MC, Pajkrt D, Wuillemin WA, et al (1998) Activation of clotting factor XI without detectable contact activation in experimental human endotoxemia. Blood 92:3294–3301

    PubMed  CAS  Google Scholar 

  42. Braat EAM, Levi M, Bos R, Haverkate F, De Maat MPM, Rijken DC (1999) The occurrence of the inactivation of single-chain urokinase-type plasminogen activator by thrombin in vivo. J Lab Clin Med 134:161–167

    Article  PubMed  CAS  Google Scholar 

  43. Quax PH, Van den Hoogen CM. Verheijen JH, et al (1990) Endotoxin induction of plasminogen activator and plasminogen activator inhibitor type 1 mRNA in rat tissues in vivo. J Biol Chem 265:15560–15563

    PubMed  CAS  Google Scholar 

  44. Sawdey MS, Loskutoff DJ (1991) Regulation of murine type I plasminogen activator inhibitor gene expression in vivo. Tissue specificity and induction by lipopolysaccharide, tumor necrosis factor-alpha, and transforming growth factor-beta. J Clin Invest 88: 1346–1353

    Article  PubMed  CAS  Google Scholar 

  45. Levi M, Van der Poll T, De Jonge E, Ten Cate H (1999) Relative insufficiency of the fibrinolytic system in disseminated intravascular coagulation. Sepsis 3:119–124

    Article  Google Scholar 

  46. Van der Poll T, Levi M, Biiller HR, et al (1991) Fibrinolytic response to tumor necrosis factor in healthy subjects. J Exp Med 174:729–732

    Article  PubMed  Google Scholar 

  47. Yamamoto K, Loskutoff DJ (1996) Fibrin deposition in tissues from endotoxin-treated mice correlates with decreases in the expression of urokinase-type but not tissue-type plasminogen activator. J Clin Invest 97:2440–2451

    Article  PubMed  CAS  Google Scholar 

  48. Levi M, Van der Poll T, Ten Cate H, et al (1998) Differential effects of anti-cytokine treatment on bronchoalveolar hemostasis in endotoxemic chimpanzees. Am J Respir Crit Care Med 158:92–98

    Article  PubMed  CAS  Google Scholar 

  49. Mesters RM, Mannucci PM, Coppola R, Keller T, Ostermann H, Kienast J (1996) Factor VIIa and antithrombin III activity during severe sepsis and septic shock in neutropenic patients. Blood 88:881–886

    PubMed  CAS  Google Scholar 

  50. Mavrommatis AC, Theodoridis Th, Orfanidou A, Roussos Ch, Christopoulou-Kokkinou V, Zakynthinos S (2000) Coagulation system and platelets are fully activated in uncomplicated sepsis. Crit Care Med 28:451–457

    Article  PubMed  CAS  Google Scholar 

  51. Gando S, Kameue T, Nanzaki S, Nakanishi Y (1996) Disseminated intravascular coagulation is a frequent complication of systemic inflammatory response syndrome. Thromb Haemost 75:224–228

    PubMed  CAS  Google Scholar 

  52. Alcaraz A, Espana F, Sánchez-Cuenca J, et al (1995) Activation of the protein C pathway in acute sepsis. Thromb Res 79:83–93

    Article  PubMed  CAS  Google Scholar 

  53. Hack CE, Nuijens JH, Strack van Schijndel RJM, Abbink JJ, Eerenberg AJM, Thijs LG (1990) A model for the interplay of inflammatory mediators in sepsis: a study in 48 patients. Intensive Care Med 16:187–191

    Article  Google Scholar 

  54. Kornelisse RF, Hazelzet JA, Savelkoul HFJ, et al (1996) The relationship between plasminogen activator inhibitor-1 and proinflammatory and counterinflammatory mediators in children with meningococcal septic shock. J Infect Dis 173:1148–1156

    Article  PubMed  CAS  Google Scholar 

  55. Fukao H, Ueshima S, Okada K, Yamamoto K, Matsuo T, Matsuo O (1992) Tissue-type plasminogen activator, type I plasminogen activator inhibitor and their complex in plasma with disseminated intravascular coagulation. Thromb Res 68:57–65

    Article  PubMed  CAS  Google Scholar 

  56. Takahashi H, Urano T, Takada Y, Nagai N, Takada A (1998) Hyperfibrinolytic activities after head injury is induced by elevated tPA activity. Fibrinolysis & Proteolysis 12:113–118

    Article  CAS  Google Scholar 

  57. Wu K, Urano T, Ihara H, et al (1995) The cleavage and inactivation of plasminogen activator inhibitor type 1 by neutrophil elastase: the evaluation of its physiologic relevance in fibrinolysis. Blood 86:1056–1061

    PubMed  CAS  Google Scholar 

  58. De Boer JP, Creasy AA, Chang A, et al (1993) Activation patterns of coagulation and fibrinolysis in baboons following infusion with lethal or sublethal of escherichia coli. Circ Shock 39:59–67

    PubMed  Google Scholar 

  59. Thijs LG, De Boer JP, De Groot MCM, Hack CE (1993) Coagulation disorders in septic shock. Intensive Care Med 19:S8–S15

    Article  PubMed  Google Scholar 

  60. Takahashi H, Tatewaki W, Wada K, Hanano M, Shibata A (1990) Thrombin versus plasmin generation in disseminated intravascular coagulation associated with various underlying disorders. Am J Hematol 33:90–95

    Article  PubMed  CAS  Google Scholar 

  61. Kidokoro A, Iba T, Fukunaga M, Yagi Y (1996) Alterations in coagulation and fibrinolysis during sepsis. Shock 5:223–228

    Article  PubMed  CAS  Google Scholar 

  62. Idell S, James KK, Levin EG, et al (1989) Local abnormalities in coagulation and fibrinolytic pathways predispose to alveolar firbin deposition in the adult respiratory distress syndrome. J Clin Invest 84:695–705

    Article  PubMed  CAS  Google Scholar 

  63. Bertozzi P, Astedt B, Zenzius L, et al (1990) Depressed bronchoalveolar urokinase activity in patients with adult respiratory distress syndrome. N Engl J Med 322:890–897

    Article  PubMed  CAS  Google Scholar 

  64. Coalson JJ (1986) Pathology of sepsis, septic shock, and multiple organ failure. In: Perspective on Sepsis and Septic Shock. Society of Critical Care Medicine, Fullerton, pp. 27–59

    Google Scholar 

  65. Fourrier F, Chopin C, Goudemand J, et al (1992) Septic shock, multiple organ failure, and disseminated intravascular coagulation. Compared patterns of antithrombin III, protein C, and protein S deficiencies. Chest 101:816–823

    Article  PubMed  CAS  Google Scholar 

  66. Asakura H, Jokaji H, Saito M, et al (1991) Plasma levels of soluble thrombomodulin increase in cases of disseminated intravascular coagulation with organ failure. Am J Hematol 38:281–287

    Article  PubMed  CAS  Google Scholar 

  67. Thijs LG (2000) Coagulation inhibitor replacement in sepsis is a potentially useful clinical approach. Crit Care Med 28:S68–S73

    Article  PubMed  CAS  Google Scholar 

  68. Coughlin SR (1999) How the protease thrombin talks to cells. Proc Natl Acad Sci USA 96:11023–11027

    Article  PubMed  CAS  Google Scholar 

  69. Esmon ChT (2000) Introduction: are natural anticoagulants candidates for modulating the inflammatory response to endotoxin?. Blood 95:1113–1116

    PubMed  CAS  Google Scholar 

  70. Johnson K, Choi Y, DeGroot E, Samuels I, Creasey A, Aarden L (1998) Potential mechanisms for a proinflammatory vascular cytokine response to coagulation activation. J Immunol 160:5130–5135

    PubMed  CAS  Google Scholar 

  71. Lorant DE, Topham MK, Whatley RE, et al (1993) Inflammatory roles of P-selectin. J Clin Invest 92:559–570

    Article  PubMed  CAS  Google Scholar 

  72. Sugama Y, Tiruppathi Ch, Janakidevi K, Andersen ThT, Fenton II JW, Malik AB (1992) Thrombin-induced expression of endothelial P-selectin and intercellular adhesion molecule-1: a mechanism for stabilizing neutrophil adhesion. J Cell Biol 119:935–944

    Article  PubMed  CAS  Google Scholar 

  73. Papapetropoulos A, Piccardoni P, Cirino G, et al (1998) Hypotension and inflammatory cytokine gene expression triggered by factor Xa-nitric oxide signaling. Proc Natl Acad Sci USA 95:4738–4742

    Article  PubMed  CAS  Google Scholar 

  74. Cirino G, Cicala C, Bucci M, et al (1997) Factor Xa as an interface between coagulation and inflammation (molecular mimicry of factor Xa association with effector cell protease receptor-1 induces acute inflammation in vivo. J Clin Invest 99:2446–2451

    Article  PubMed  CAS  Google Scholar 

  75. Senden NHM, Jeunhomme TMAA, Heemskerk JWM, et al (1998) Factor Xa induces cytokine production and expression of adhesion molecules by human umbilical vein endothelial cells. J Immunol 161:4318–4324

    PubMed  CAS  Google Scholar 

  76. Camerer E, Rottingen J-A, Gjernes E, et al (1999) Coagulation factors VIIa and Xa induce cell signaling leading to up-regulation of the egr-1 gene. J Biol Chem 274:32225–32233

    Article  PubMed  CAS  Google Scholar 

  77. Cunningham MA, Romas P, Hutchinson P, Holdsworth SR, Tipping PG (1999) Tissue factor and factor VIIa receptor/ligand interactions induce proinflammatory effects in macrophages. Blood 94:3413–3420

    PubMed  CAS  Google Scholar 

  78. Nystedt S, Ramakrishnan V, Sundelin J (1996) The proteinase-activated receptor 2 is induced by inflammatory mediators in human endothelial cells: comparison with the thrombin receptor. J Biol Chem 271:14910–14916

    Article  PubMed  CAS  Google Scholar 

  79. Vergnolle N (1999) Proteinase-activated receptor-2-activating peptides induce leukocyte rolling, adhesion, and extravasation in vivo. J Immunol 163:5064–5069

    PubMed  CAS  Google Scholar 

  80. Robson SC, Shephard EG Kirsch RE (1994) Fibrin degradation product D-dimer induces the synthesis and release of biologically active IL-IB, IL-6 and plasminogen activator inhibitors from monocytes in vitro. Br J Haematol 86:322–326

    Article  PubMed  CAS  Google Scholar 

  81. Colman RW (1999) Biologic activities of the contact factors in vivo. Potentiation of hypotension, inflammation, and fibrinolysis, and inhibition of cell adhesion, angiogenesis and thrombosis. Thromb Haemost 82:1568–1577

    PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. Medical Intensive Care Unit, Academic Hospital Free University, P.O. Box 7057, 1007, MB Amsterdam, The Netherlands

    L. G. Thijs

Authors
  1. L. G. Thijs
    View author publications

    You can also search for this author in PubMed Google Scholar

Editor information

Editors and Affiliations

  1. Intensive Care Unit, Royal Brompton Hospital, Sydney Street, London, SW3 6NP, UK

    Timothy W. Evans

  2. Division of Critical Care Medicine, University of Pittsburgh Medical Center, Scaife Hall, Room 606, 3550 Terrace Street, Pittsburgh, PA, 15264, USA

    Mitchell P. Fink

Rights and permissions

Reprints and permissions

Copyright information

© 2002 Springer-Verlag Berlin Heidelberg

About this chapter

Cite this chapter

Thijs, L.G. (2002). Coagulation Abnormalities in Critical Illness. In: Evans, T.W., Fink, M.P. (eds) Mechanisms of Organ Dysfunction in Critical Illness. Update in Intensive Care and Emergency Medicine, vol 38. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-56107-8_27

Download citation

  • DOI: https://doi.org/10.1007/978-3-642-56107-8_27

  • Publisher Name: Springer, Berlin, Heidelberg

  • Print ISBN: 978-3-540-42692-9

  • Online ISBN: 978-3-642-56107-8

  • eBook Packages: Springer Book Archive

Publish with us

Policies and ethics

Search

Navigation